# A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

> **NCT00195429** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 47 (actual)

## Conditions studied

- Kidney Failure
- Graft vs Host Disease

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Sirolimus
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00195429
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195429, "A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00195429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*